Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1

Journal of Lipid Research

Volumn 51, Issue 8, 2010, Pages 2018-2031

  Bazan, Nicolas G ^a   Calandria, Jorgelina M ^a   Serhan, Charles N ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

15 lipoxygenase 1; Age related macular degeneration; Neurotrophins; Oxidative stress; Retinal pigment epithelial cells

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; DOCOSAHEXAENOIC ACID; INHIBITOR OF APOPTOSIS PROTEIN; NEUROPROTECTIN D1; NEUROTROPHIN; UNCLASSIFIED DRUG; NERVE GROWTH FACTOR; PROTECTIN D1;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CELL LOSS; CELL PROTECTION; CELL REGENERATION; CELL RENEWAL; CELL SURVIVAL; ENZYME ACTIVITY; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTOSIS; PHOTORECEPTOR CELL; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RETINA DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; SUBRETINAL NEOVASCULARIZATION; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; METABOLISM; SECRETION (PROCESS); VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; DOCOSAHEXAENOIC ACIDS; HUMANS; NERVE GROWTH FACTORS; OXIDATIVE STRESS; PHOTORECEPTOR CELLS; RETINAL PIGMENT EPITHELIUM;

EID: 77956460474     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R001131     Document Type: Review

References (111)

1. Papermaster, D. S. 2002. The birth and death of photoreceptors: the Friedenwald Lecture. Invest. Ophthalmol. Vis. Sci. 43: 1300-1309.
2. Rattner, A., and J. Nathans. 2006. Macular degeneration: recent advances and therapeutic opportunities. Nat. Rev. Neurosci. 7: 860-872.
3. Chang, G. Q., Y. Hao, and F. Wong. 1993. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron. 11: 595-605.
4. Portera-Cailliau, C., C. H. Sung, J. Nathans, and R. Adler. 1994. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA. 91: 974-978.
5. Bird, A. C. 2003. The Bowman lecture. Towards an understanding of age-related macular disease. Eye (Lond.). 17: 457-466.
6. Liu, Q., J. Zuo, and E. A. Pierce. 2004. The retinitis pigmentosa 1 protein is a photoreceptor microtubule-associated protein. J. Neurosci. 24: 6427-6436.
7. Dryja, T. P., T. L. McGee, E. Reichel, L. B. Hahn, G. S. Cowley, D. W. Yandell, M. A. Sandberg, and E. L. Berson. 1990. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 343: 364-366.
8. Mendes, H. F., J. van der Spuy, J. P. Chapple, and M. E. Cheetham. 2005. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol. Med. 11: 177-185.
9. de Jong, P. T. 2006. Age-related macular degeneration. N. Engl. J. Med. 355: 1474-1485.
10. Sreekumar, P. G., R. Kannan, J. Yaung, C. K. Spee, S. J. Ryan, and D. R. Hinton. 2005. Protection from oxidative stress by methionine sulfoxide reductases in RPE cells. Biochem. Biophys. Res. Commun. 334: 245-253.
11. Shen, J. K., A. Dong, S. F. Hackett, W. R. Bell, W. R. Green, and P. A. Campochiaro. 2007. Oxidative damage in age-related macular degeneration. Histol. Histopathol. 22: 1301-1308.
12. Dunaief, J. L., T. Dentchew, G. S. Ying, and A. H. Milam. 2002. The role of apoptosis in age-related macular degeneration. Arch. Ophthalmol. 120: 1435-1442.
13. Feher, J., I. Kovacs, M. Artico, C. Cavallotti, A. Papale, and C. Balacco Gabrieli. 2006. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol. Aging. 27: 983-993.
14. Hageman, G. S., D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, et al. 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisphotoreceptor outer segment es individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA. 102: 7227-7232.
15. Klein, R. J., C. Zeiss, E. Y. Chew, J. Y. Tsai, R. S. Sackler, C. Haynes, A. K. Henning, J. P. SanGiovanni, S. M. Mane, S. T. Mayne, et al. 2005. Complement factor H polymorphism in age-related macular degeneration. Science. 308: 385-389.
16. Edwards, A. O., R. Ritter III, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer. 2005. Complement factor H polymorphism and age-related macular degeneration. Science. 308: 421-424.
17. Haines, J. L., M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson, P. Gallins, K. L. Spencer, S. Y. Kwan, M. Noureddine, J. R. Gilbert, et al. 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science. 308: 419-421.
18. Gold, B., J.E. Merriam, J. Zernant, L.S. Hancox, A.J. Taiber, K. Gehrs, K. Cramer, J. Neel, J. Bergeron, G.R. Barile, et al. 2006. Variation in factor B (BF) and complement 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38: 458-462.
19. Bok, D. 2005. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc. Natl. Acad. Sci. USA. 102: 7053-7054.
20. Spencer, K. L., M. A. Hauser, L. M. Olson, S. Schmidt, W. K. Scott, P. Gallins, A. Agarwal, E. A. Postel, M. A. Pericak-Vance, and J. L. Haines. 2007. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum. Mol. Genet. 16: 1986-1992.
21. Pournaras, C. J., E. Rungger-Brändle, C. E. Riva, S. H. Hardarson, and E. Stefansson. 2008. Regulation of retinal blood flow in health and disease. Prog. Retin. Eye Res. 27: 284-330.
22. Strauss, O. 2005. The retinal pigment epithelium in visual function. Physiol. Rev. 85: 845-881.
23. Wang, J. S., and V. J. Kefalov. 2009. An alternative pathway mediates the mouse and human cone visual cycle. Curr. Biol. 19: 1665-1669.
24. Navid, A., S. C. Nicholas, and R. D. Hamer. 2006. A proposed role for all-trans retinal in regulation of rhodopsin regeneration in human rods. Vision Res. 46: 4449-4463.
25. Saari, J. C. 2000. Biochemistry of visual pigment regeneration: the Friedenwald lecture. Invest. Ophthalmol. Vis. Sci. 41: 337-348.
26. Lamb, T. D., and E. N. Pugh, Jr. 2004. Dark adaptation and the retinoid cycle of vision. Prog. Retin. Eye Res. 23: 307-380.
27. Besch, D., H. Jägle, H. P. N. Scholl, M. W. Seeliger, and E. Zrenner. 2003. Inherited multifocal RPE-diseases: mechanisms for local dysfunction in global retinoid cycle gene defects. Vision Res. 43: 3095-3108.
28. Cideciyan, A. V., T. S. Aleman, M. Swider, S. B. Schwartz, J. D. Steinberg, A. J. Brucker, A. M. Maguire, J. Bennett, E. M. Stone, and S. G. Jacobson. 2004. Mutations in ABCA4 result in accumulation of lipofucsin before slowing the retinoid cycle: a reappraisal of the human disease sequence. Hum. Mol. Genet. 13: 525-534.
29. Zlokovic, B. V. 2005. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 28: 202-208.
30. Zhao, S., and P. A. Overbeek. 2001. Regulation of choroid development by the retinal pigment epithelium. Mol. Vis. 2: 277-282.
31. Lee, S. J., J. H. Kim, J. H. Kim, M. J. Chung, Q. Wen, H. Chung, K. W. Kim, and Y. S. Yu. 2007. Human apolipoprotein E2 transgenic mice show lipid accumulation in retinal pigment epithelium and altered expression of VEGF and bFGF in the eyes. J. Microbiol. Biotechnol. 17: 1024-1030.
32. Gao, G., Y. Li, D. Zhang, S. Gee, C. Crosson, and J. Ma. 2001. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 489: 270-276.
33. Dawson, D. W., O. V. Volpert, P. Gillis, S. E. Crawford, H. Xu, W. Benedict, and N. P. Bouck. 1999. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 285: 245-248.
34. Bok, D. 1993. The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci. Suppl. 17: 189-195.
35. Kolko, M., J. Wang, C. Zhan, K. A. Poulsen, J. U. Prause, M. H. Nissen, S. Heegaard, and N. G. Bazan. 2007. Identification of intracellular phospholipases A2 in the human eye: involvement in phagocytosis of photoreceptor outer segments. Invest. Ophthalmol. Vis. Sci. 48: 1401-1409.
36. LaVail, M. M. 1980. Circadian nature of rod outer segment disc shedding in the rat. Invest. Ophthalmol. Vis. Sci. 19: 407-411.
37. Young, R. W., and B. Droz. 1968. The renewal of protein in retinal rods and cones. J. Cell Biol. 39: 169-184.
38. Young, R. W. 1971. The renewal of the rod and cone outer segments in the rhesus monkey. J. Cell Biol. 49: 303-318.
39. Gao, H., and J. G. Hollyfield. 1992. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 33: 1-17.
40. Gibbs, D., J. Kitamoto, and D. S. Williams. 2003. Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein. Proc. Natl. Acad. Sci. USA. 100: 6481-6486.
41. Bazan, N. G. 2006. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci. 29: 263-271.
42. Bazan, N. G. 2007. Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 48: 4866-4881.
43. Chen, M., J. V. Forrester, and H. Xu. 2007. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp. Eye Res. 84: 635-645.
44. Mukherjee, P. K., V. L. Marcheselli, J. C. de Rivero Vaccari, W. C. Gordon, F. E. Jackson, and N. G. Bazan. 2007. Photoreceptor outer segment phagocytosis selectively attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc. Natl. Acad. Sci. USA. 104: 13158-13163.
45. Dunn, K. C., A. E. Aotaki-Keen, F. R. Putkey, and L. M. Hjelmeland. 1996. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62: 155-169.
46. Mukherjee, P. K., V. L. Marcheselli, C. N. Serhan, and N. G. Bazan. 2004. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA. 101: 8491-8496.
47. Marcheselli, V. L., S. Hong, W. J. Lukiw, X. H. Tian, K. Gronert, A. Musto, M. Hardy, J. M. Gimenez, N. Chiang, C. N. Serhan, et al. 2003. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278: 43807-43817.
48. SanGiovanni, J. P., and E. Y. Chew. 2005. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 24: 87-138.
49. Marszalek, J. R., and H. F. Lodish. 2005. Docosahexaenoic acid, fatty acid interacting proteins, and neuronal function: breast milk and fish are good for you. Annu. Rev. Cell Dev. Biol. 21: 633-657.
50. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237: 1171-1176.
51. Serhan, C. N., S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R-L. Moussignac. 2002. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J. Exp. Med. 196: 1025-1037.
52. Hong, S., K. Gronert, P. Devchand, R-L. Moussignac, and C. N. Serhan. 2003. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J. Biol. Chem. 278: 14677-14687.
53. H2 skewing and promotes human T cell apoptosis via lipid raft clustering. J. Biol. Chem. 280: 43079-43086.
54. Serhan, C. N., K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S. P. Colgan, and N. A. Petasis. 2006. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176: 1848-1859.
55. Marcheselli, V. L., P. K. Mukherjee, M. Arita, S. Hong, R. Antony, K. Sheets, N. Petasis, C. N. Serhan, and N. G. Bazan. 2010. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot. Essent. Fatty Acids. 82: 27-34.
56. Serhan, C. N. 2007. Resolution phases of inflammation: novel endogenous anti-inflammatory and pro-resolving lipid mediators and pathways. Annu. Rev. Immunol. 25: 101-137.
57. Serhan, C. N., N. Chiang, and T. E. Van Dyke. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8: 349-361.
58. Bazan, N. G., D. L. Birkle, and T. S. Reddy. 1984. Docosahexaenoic acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina. Biochem. Biophys. Res. Commun. 125: 741-747.
59. Serhan, C. N., C. B. Clish, J. Brannon, S. P. Colgan, N. Chiang, and K. Gronert. 2000. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192: 1197-1204.
60. Arita, M., F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N. A. Petasis, and C. N. Serhan. 2005. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201: 713-722.
61. Serhan, C. N., U. Lundberg, G. Weissmann, and B. Samuelsson. 1984. Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate. Prostaglandins. 27: 563-581.
62. Bannenberg, G. L., N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K. H. Gotlinger, S. Hong, and C. N. Serhan. 2005. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174: 4345-4355.
63. Schwab, J. M., N. Chiang, M. Arita, and C. N. Serhan. 2007. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 447: 869-874.
64. Butovich, I. A. 2005. On the structure and synthesis of neuroprotectin D1, a novel anti-inflammatory compound of the docosahexaenoic acid family. J. Lipid Res. 46: 2311-2314.
65. Levy, B. D., P. Kohli, K. Gotlinger, O. Haworth, S. Hong, S. Kazani, E. Israel, K. J. Haley, and C. N. Serhan. 2007. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 178: 496-502.
66. Lukiw, W. J., J. G. Cui, V. L. Marcheselli, M. Bodker, A. Botkjaer, K. Gotlinger, C. N. Serhan, and N. G. Bazan. 2005. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115: 2774-2783.
67. Poulsen, R. C., K. H. Gotlinger, C. N. Serhan, and M. C. Kruger. 2008. Identification of inflammatory and pro-resolving lipid mediators in bone marrow and their profile alteration with ovariectomy and omega-3 intake. Am. J. Hematol. 83: 437-445.
68. Duffield, J. S., S. Hong, V. Vaidya, Y. Lu, G. Fredman, C. N. Serhan, and J. V. Bonventre. 2006. Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 177: 5902-5911.
69. Sun, Y-P., S. F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S. P. Colgan, N. A. Petasis, and C. N. Serhan. 2007. Resolvin D1 and its aspirin-triggered 17 R epimer: stereochemical assignments, anti-inflammatory properties and enzymatic inactivation. J. Biol. Chem. 282: 9323-9334.
70. Blaho, V. A., M. W. Buczynski, C. R. Brown, and E. A. Dennis. 2009. Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis. J. Biol. Chem. 284: 21599-21612.
71. Qin, Q., K. A. Patil, K. Gronert, and S. C. Sharma. 2008. Neuroprotectin D1 inhibits retinal ganglion cell death following axotomy. Prostaglandins Leukot. Essent. Fatty Acids. 79: 201-207.
72. Hassan, I. R., and K. Gronert. 2009. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J. Immunol. 182: 3223-3232.
73. González-Périz, A., R. Horrillo, N. Ferré, K. Gronert, B. Dong, E. Morán-Salvador, E. Titos, M. Martínez- Clemente, M. López-Parra, V. Arroyo, et al. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23: 1946-1957.
74. Chen, P., B. Fenet, S. Michaud, N. Tomczyk, E. Véricel, M. Lagarde, and M. Guichardant. 2009. Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett. 583: 3478-3484.
75. Hong, S., E. Tjonahen, E. L. Morgan, L. Yu, C. N. Serhan, and A. F. Rowley. 2005. Rainbow trout ( Oncorhynchus mykiss ) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-mediator lipidomic analysis. Prostaglandins Other Lipid Mediat. 78: 107-116.
76. Tanihara, H., M. Inatani, and Y. Honda. 1997. Growth factors and their receptors in the retina and pigment epithelium. Prog. Retin. Eye Res. 16: 271-301.
77. LaVail, M. M., D. Yasumura, M. T. Matthes, C. Lau-Villacorta, K. Unoki, C. H. Sung, and R. H. Steinberg. 1998. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest. Ophthalmol. Vis. Sci. 39: 592-602.
78. Politi, L. E., N. P. Rotstein, and N. G. Carri. 2001. Effect of GDNF on neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. Invest. Ophthalmol. Vis. Sci. 42: 3008-3015.
79. Hu, J., and D. Bok. 2001. A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol. Vis. 7: 14-19.
80. Mukherjee, P. K., V. L. Marcheselli, S. Barreiro, J. Hu, D. Bok, and N. G. Bazan. 2007. Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc. Natl. Acad. Sci. USA. 104: 13152-13157.
81. Bazan, N. G., D. L. Birkle, and T. S. Reddy. 1985. Biochemical and nutritional aspects of the metabolism of polyunsaturated fatty acids and phospholipids in experimental models of retinal degeneration. In Retinal Degeneration: Experimental and Clinical Studies. M.M. LaVail, J.G. Hollyfield, and R.E. Anderson, editors. Alan R. Liss, Inc. New York, NY. 159-187.
82. Bazan, N. G. 2003. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J. Lipid Res. 44: 2221-2233.
83. Aveldano, M. I., and N. G. Bazan. 1974. Displacement into incubation medium by albumin of highly unsaturated retina free fatty acids arising from membrane lipids. FEBS Lett. 40: 53-56.
84. Aveldano, M. I., and N. G. Bazan. 1975. Differential lipid deacylation during brain ischemia in a homeotherm and a poikilotherm. Content and comphotoreceptor outer segment ition of free fatty acids and triacylglycerols. Brain Res. 100: 99-110.
85. Horrocks, L. A., and A. A. Farooqui. 1994. NMDA receptor-stimulated release of arachidonic acid: mechanisms for the Bazan effect. In Cell Signal Transduction, Second Messengers, and Protein Phosphorylation in Health and Disease. A.M. Municio and M.T. Miras-Portugal, editors. Plenum Press, New York, NY. 113-128.
86. Sun, G. Y., J. Xu, M. D. Jensen, and A. Simonyi. 2004. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45: 205-213.
87. Reddy, T. S., and N. G. Bazan. 1984. Activation of polyunsaturated fatty acids by rat tissues in vitro. Lipids. 19: 987-989.
88. Reddy, T. S., and N. G. Bazan. 1984. Synthesis of arachidonoyl coenzyme A and docosahexaenoyl coenzyme A in retina. Curr. Eye Res. 3: 1225-1232.
89. Reddy, T. S., and N. G. Bazan. 1985. Synthesis of arachidonoyl coenzyme A and docosahexaenoyl coenzyme A in synaptic plasma membranes of cerebrum and microsomes of cerebrum, cerebellum, and brain stem of rat brain. J. Neurosci. Res. 13: 381-390.
90. Reddy, T. S., and N. G. Bazan. 1985. Synthesis of docosahexaenoyl-, arachidonoyl- and palmitoyl-coenzyme A in ocular tissues. Exp. Eye Res. 41: 87-95.
91. Calandria, J. M., V. L. Marcheselli, P. K. Mukherjee, J. Uddin, J. W. Winkler, N. A. Petasis, and N. G. Bazan. 2009. Selective survival rescue in 15-lipoxygenase-1 deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1. J. Biol. Chem. 284: 17877-17882.
92. Kühn, H., B. J. Thiele, A. Ostareck-Lederer, H. Stender, H. Suzuki, T. Yoshimoto, and S. Yamamoto. 1993. Bacterial expression, purification and partial characterization of recombinant rabbit reticulocyte 15-lipoxygenase. Biochim. Biophys. Acta. 1168: 73-78.
93. Brash, A. R., W. E. Boeglin, and M. S. Chang. 1997. Discovery of a second 15S-lipoxygenase in humans. Proc. Natl. Acad. Sci. USA. 94: 6148-6152.
94. Bryckaert, M., X. Guillonneau, C. Hecquet, Y. Courtois, and F. Mascarelli. 1999. Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2. Oncogene. 18: 7584-7593.
95. Bilak, M. M., D. A. Shifrin, A. M. Corse, S. R. Bilak, and R. W. Kuncl. 1999. Neuroprotective utility and neurotrophic action of neurturin in photoreceptor outer segment tnatal motor neurons: comparison with GDNF and persephin. Mol. Cell. Neurosci. 13: 326-336.
96. Milbrandt, J., F. J. de Sauvage, T. J. Fahrner, R. H. Baloh, M. L. Leitner, M. G. Tansey, P. A. Lampe, R. O. Heuckeroth, P. T. Kotzbauer, K. S. Simburger, et al. 1998. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron. 20: 245-253.
97. Kannan, R., N. Zhang, P. G. Sreekumar, C. K. Spee, A. Rodriguez, E. Barron, and D. R. Hinton. 2006. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Mol. Vis. 12: 1649-1659.
98. Bhutto, I. A., D. S. McLeod, T. Hasegawa, S. Y. Kim, C. Merges, P. Tong, and G. A. Lutty. 2006. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp. Eye Res. 82: 99-110.
99. Frank, R. N., R. H. Amin, D. Eliott, J. E. Puklin, and G. W. Abrams. 1996. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am. J. Ophthalmol. 122: 393-403.
100. Frank, R. N. 1997. Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res. 29: 341-353.
101. Frank, R. N., R. H. Amin, and J. E. Puklin. 1999. Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration. Am. J. Ophthalmol. 127: 694-709.
102. Mattson, M. P., and N. G. Bazan. 2006. Apoptosis and necrosis. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 7th ed. G.J. Siegel, R.W. Albers, S.T. Brady, and D.L. Price, editors. Elsevier Academic Press, Burlington, MA. 603-615.
103. Hinton, D. R., S. He, and P. F. Lopez. 1998. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch. Ophthalmol. 116: 203-209.
104. Sparrow, J. R., and B. Cai. 2001. Blue light-induced apoptosis of A2E containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest. Ophthalmol. Vis. Sci. 42: 1356-1362.
105. Chen, L., W. Wu, T. Dentchev, Y. Zeng, J. Wang, I. Tsui, J. W. Tobias, J. Bennett, D. Baldwin, and J. L. Dunaief. 2004. Light damage induced changes in mouse retinal gene expression. Exp. Eye Res. 79: 239-247.
106. Stuart, J. K., D. G. Myszka, L. Joss, R. S. Mitchell, S. M. McDonald, Z. Xie, S. Takayama, J. C. Reed, and K. R. Ely. 1998. Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperones. J. Biol. Chem. 273: 22506-22514.
107. Takayama, S., D. N. Bimston, S. Matsuzawa, B. C. Freeman, C. Aime-Sempe, Z. Xie, R. I. Morimoto, and J. C. Reed. 1997. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 16: 4887-4896.
108. Takayama, S., Z. Xie, and J. C. Reed. 1999. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J. Biol. Chem. 274: 781-786.
109. Belvisi, M. G., M. A. Saunders, E. B. Haddad, S. J. Hirst, M. H. Yacoub, P. J. Barnes, and J. A. Mitchell. 1997. Induction of cyclooxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br. J. Pharmacol. 120: 910-916.
110. Ershov, A. V., and N. G. Bazan. 1999. Induction of cyclooxygenase-2 gene expression in retinal pigment epithelium cells by photoreceptor rod outer segment phagocytosis and growth factors. J. Neurosci. Res. 58: 254-261.
111. Sheets, K. G., Y. Zhou, M. E. Ertel, E. J. Knott, C. E. Regan, Jr., J. R. Elison, W. C. Gordon, P. Gjorstrup, and N. G. Bazan. 2010. Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse. Mol. Vis. 16: 320-329.